Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
City of Hope Medical Center
Case Comprehensive Cancer Center
Pfizer
OHSU Knight Cancer Institute
Prelude Therapeutics
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Medigene AG
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
University of Wisconsin, Madison
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
California Cancer Consortium
Massachusetts General Hospital
University of Louisville
Yale University
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Indiana University
Indiana University
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Alaunos Therapeutics
Northwestern University
Northwestern University
Novartis
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center